Imrecoxib is a chemical compound under investigation as an active pharmaceutical ingredient. It has been evaluated in clinical trials for the management of knee osteoarthritis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 395683-14-4
Triamterene
pharmaceutical raw material
Pasireotide
pharmaceutical raw material
Methacycline hydrochloride
pharmaceutical raw material
Fluticasone furoate
pharmaceutical raw material
4-(4-methylphenyl)-3-(4-methylsulfonylphenyl)-1-propyl-2H-pyrrol-5-one
AXMZZGKKZDJGAZ-UHFFFAOYSA-N
CCCN1CC(=C(C1=O)C2=CC=C(C=C2)C)C3=CC=C(C=C3)S(=O)(=O)C